U.S. Supreme Court
Jun. 26, 2013
Generic drugmakers score victory in U.S. Supreme Court
Defense attorneys on Monday cheered a U.S. Supreme Court ruling, which held that someone who takes a generic drug cannot sue the manufacturer for warning labels that are consistent with their brand-name counterparts.
Daily Journal Staff Writer
California defense attorneys heralded a U.S. Supreme Court ruling Monday protecting generic drugmakers from lawsuits over warning labels.
The court ruled that someone who takes a generic drug cannot sue the manufacturer for not adequately warning them of possible side effects - so long as the generic warning label matches its brand-name equivalent.
Defense attorneys consider the ruling a vi...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In